The results, published Monday in NEJM Evidence, represent the first randomized clinical trial exploring semaglutide use in people with Type 1 diabetes, for whom the drug is not currently FDA approved
If you want a clearer next step, you can take the free assessment quiz to see whether a prescription program is a fit
Common side effects include: Nasopharyngitis and upper respiratory tract infections the most frequently reported adverse effects (mechanism not fully established) Headache and dizziness reported in some patients, particularly during the initial weeks of treatment Gastrointestinal symptoms such as nausea or constipation, though these are generally mild Less common but important safety considerations include: Hypoglycaemia : Although the risk is low when a gliptin is used alone or with metformin, it increases when combined with a sulfonylurea or insulin
But beneath the surface level unease something important happened
Hair thinning can feel confusing and personal
What Causes Gas After Hysterectomy
